Gustave Roussy immune score predicts survival outcome of patients with metastatic urothelial carcinoma treated with pembrolizumab: A multicenter study of 321 patients (YUSHIMA study)

被引：0
|
作者：
Tanabe, K. [1 ]
Shuichiro, K. [1 ]
Katsushi, N. [2 ]
Junji, Y. [3 ]
Yukihiro, O. [4 ]
Tetsuo, O. [5 ]
Ryoji, T. [6 ]
Akira, N. [1 ]
Masataka, Y. [7 ]
Tetsuro, T. [8 ]
Kazutaka, S. [9 ]
Yasuyuki, S. [10 ]
Fumitaka, K. [11 ]
Yukio, K. [12 ]
Hajime, T. [13 ]
Soichiro, Y. [13 ]
Yasuhisa, F. [13 ]
机构：
[1] Saitama Red Cross Hosp, Dept Urol, Saitama, Japan
[2] Kohnodai Hosp, Dept Urol, Chiba, Japan
[3] Canc Inst Hosp, Dept Urol, Tokyo, Japan
[4] Japanese Red Cross Omori Hosp, Dept Urol, Tokyo, Japan
[5] JA Toride Med Ctr, Dept Urol, Ibaraki, Japan
[6] Tokyo Metropolitan Otsuka Hosp, Dept Urol, Tokyo, Japan
[7] Tokyo Metropolitan Tama Nambu Chiiki Hosp, Dept Urol, Tokyo, Japan
[8] Showa Gen Hosp, Dept Urol, Tokyo, Japan
[9] Dokkyo Med Univ Saitama Med Ctr, Dept Urol, Saitama, Japan
[10] Tsuchiura Kyodo Gen Hosp, Dept Urol, Ibaraki, Japan
[11] Komagome Hosp, Dept Urol, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
[12] Saitama Prefectural Canc Ctr, Dept Urol, Saitama, Japan
[13] Tokyo Med & Dent Univ, Dept Urol, Tokyo, Japan
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0752
引用
收藏
页码：S1729 / S1730
页数：2
相关论文
共 50 条
  • [41] Clinical Impact of Sarcopenia and Inflammatory/Nutritional Markers in Patients with Unresectable Metastatic Urothelial Carcinoma Treated with Pembrolizumab
    Shimizu, Takuto
    Miyake, Makito
    Hori, Shunta
    Ichikawa, Kazuki
    Omori, Chihiro
    Iemura, Yusuke
    Owari, Takuya
    Itami, Yoshitaka
    Nakai, Yasushi
    Anai, Satoshi
    Tomioka, Atsushi
    Tanaka, Nobumichi
    Fujimoto, Kiyohide
    DIAGNOSTICS, 2020, 10 (05)
  • [42] Gustave Roussy immune score is a prognostic marker in patients with small cell lung cancer undergoing immunotherapy: a real-world retrospective study
    Jian, Shangguan
    Huang, Xinyi
    Liu, Xu
    Zhang, Zengfu
    Zhang, Xiaodong
    Yu, Jinming
    Chen, Dawei
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [43] Association of baseline modified Glasgow Prognostic Score (mGPS) with survival outcomes in patients with metastatic urothelial cell carcinoma (mUCC) treated with immune checkpoint inhibitors (CPI)
    Brown, Jacqueline T.
    Liu, Yuan
    Shabto, Julie M.
    Martini, Dylan J.
    Ravindranathan, Deepak
    Hitron, Elise
    Russler, Greta
    Caulfield, Sarah
    Yantorni, Lauren Beth
    Joshi, Shreyas S.
    Kissick, Haydn
    Ogan, Kenneth
    Harris, Wayne
    Carthon, Bradley Curtis
    Kucuk, Omer
    Master, Viraj A.
    Bilen, Mehmet Asim
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [44] Novel Inflammation-Based Prognostic Score for Predicting Survival in Patients with Metastatic Urothelial Carcinoma
    Su, Yu-Li
    Hsieh, Meng-Che
    Chiang, Po-Hui
    Sung, Ming-Tse
    Lan, Jui
    Luo, Hao-Lun
    Huang, Chun-Chieh
    Huang, Cheng-Hua
    Tang, Yeh
    Rau, Kun-Ming
    PLOS ONE, 2017, 12 (01):
  • [45] A Gleason score of 7 predicts a worse outcome for prostate carcinoma patients treated with radiotherapy
    Green, GA
    Hanlon, AL
    Al-Saleem, T
    Hanks, GE
    CANCER, 1998, 83 (05) : 971 - 976
  • [46] Association of the Lung Immune Prognostic Index with outcome in patients with metastatic urothelial cancer treated with immune checkpoint inhibitor
    Pauline, Parent
    Auclin, Edouard
    Mezquita, Laura
    Chanza, Nieves M.
    Dumont, Clement
    Rodriguez-Vida, Alejo
    Lozano, Rebeca
    Vera, Beatriz
    Ratta, Raffaele
    Baciarello, Giulia
    Colomba, Emeline
    Fuerea, Alina
    Besse, Benjamin
    Loriot, Yohann
    Lavaud, Pernelle
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [47] Sarcopenia predicts outcomes in patients with hepatocellular carcinoma treated with atezolizumab and bevacizumab: A multicenter cohort study
    Nam, H.
    Kim, Y.
    Park, H.
    ANNALS OF ONCOLOGY, 2023, 34 : S128 - S128
  • [48] Prognostic significance of the albumin-to-globulin ratio for advanced urothelial carcinoma treated with pembrolizumab: a multicenter retrospective study
    Satoru Taguchi
    Taketo Kawai
    Tohru Nakagawa
    Yu Nakamura
    Jun Kamei
    Daisuke Obinata
    Kenya Yamaguchi
    Tomoyuki Kaneko
    Shigenori Kakutani
    Mayuko Tokunaga
    Yukari Uemura
    Yusuke Sato
    Tetsuya Fujimura
    Hiroshi Fukuhara
    Yutaka Enomoto
    Hiroaki Nishimatsu
    Satoru Takahashi
    Haruki Kume
    Scientific Reports, 11
  • [49] Combining serum inflammatory markers and clinical factors to predict survival in metastatic urothelial carcinoma patients treated with immune checkpoint inhibitors
    Cheng, Liang-Yun
    Su, Po-Jung
    Kuo, Ming-Chun
    Lin, Chang-Ting
    Luo, Hao-Lun
    Chou, Chih-Chi
    Huang, Shih-Yu
    Wu, Chia-Che
    Chen, Chien-Hsu
    Huang, Chun-Chieh
    Tsai, Kai-Lung
    Su, Harvey Yu-Li
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [50] Prognostic significance of the albumin-to-globulin ratio for advanced urothelial carcinoma treated with pembrolizumab: a multicenter retrospective study
    Taguchi, Satoru
    Kawai, Taketo
    Nakagawa, Tohru
    Nakamura, Yu
    Kamei, Jun
    Obinata, Daisuke
    Yamaguchi, Kenya
    Kaneko, Tomoyuki
    Kakutani, Shigenori
    Tokunaga, Mayuko
    Uemura, Yukari
    Sato, Yusuke
    Fujimura, Tetsuya
    Fukuhara, Hiroshi
    Enomoto, Yutaka
    Nishimatsu, Hiroaki
    Takahashi, Satoru
    Kume, Haruki
    SCIENTIFIC REPORTS, 2021, 11 (01)
12345